EU approves treatment for prostate cancer

Glass laboratory flasks on light table

The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.

UK announces mass genome sequencing programme for newborns

Previous article

Clinical efficacy and safety of two injections of a bivalent vaccine as a primary series during a period of Omicron circulation

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations